Health Condition 1: K117- Disturbances of salivary secretion
Conditions
Interventions
Intervention1: TENS therapy (2 session per week and 20 minutes per session for a period of 3 months): A device called transcutaneous electrical nerve stimulation (TENS) uses electric current that is m
Sponsors
NIL
Eligibility
Inclusion criteria
Inclusion criteria: Participants who meet the eligibility requirements for the study are those who have completed radiation therapy with or without chemotherapy or surgery between three months and two years prior to study entry, and who report symptoms of oral dryness and decreased salivary flow (= 0.2 mL/min). All participants who are willing to give written informed consent.
Exclusion criteria
Exclusion criteria: Participants with a history of known salivary gland pathologies, such as rheumatoid arthritis and Sjogrens syndrome. Those who are taking drugs like pilocarpine, cevimeline, inhalatory glucocorticoids, opioids, benzodiazepines, diuretics, or who have undergone surgery involving the salivary glands. Participants with hearing aids, cochlear implants, pacemakers or defibrillators will be excluded from the study. Participants who have peptic ulcers or uncontrolled asthma will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in the salivary flowTimepoint: Baseline, 1month, 3 months and 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| OHI-S scores.Timepoint: Baseline, 1 month, 3 months and 6 months;Oral dryness.Timepoint: Baseline, 1 month, 3 months and 6 months;pH and viscosity of saliva.Timepoint: Baseline, 1 month, 3 months and 6 months;Quality of life.Timepoint: Baseline, 1 month, 3 months and 6 months | — |
Countries
India
Contacts
Public ContactDr.Arpit Gupta
Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh
Outcome results
None listed